ANI PHARMACEUTICALS INC — Director's Dealing 2023

Aug 16, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2023-08-11

Reporting Person: Lalwani Nikhil (Director, PRESIDENT & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-08-11	Common Stock	S	56666	$57.75	Disposed	353390	Direct
2023-08-15	Common Stock	M	11616	$29	Acquired	365006	Direct
2023-08-15	Common Stock	S	11616	$61.13	Disposed	353390	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-08-15	Stock Option (right to buy)	$29	M	11616	Disposed	2030-09-08	Common Stock (11616)	Direct

Footnotes

F1: Reflects the weighted average price of sales on August 15, 2023. The shares were sold in multiple transactions at prices ranging from $60.68 to $61.87, inclusive.

F2: 25% of the total options vested on each of September 8, 2021 and September 8, 2022. 25% of the total options will vest on each of September 8, 2023 and September 8, 2024.